Related Experiment Video
Updated: Jul 15, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
Published on: February 15, 2022
Lifetime visual disability in open-angle glaucoma and ocular hypertension.
Eva Forsman1, Tero Kivelä, Eija Vesti
1Population Genetics Unit, Folkhälsan Institute of Genetics, University of Helsinki, Helsinki, Finland. eforsman@elisanet.fi
This study found that 14% of patients with treated glaucoma or ocular hypertension became blind, with advanced disease, fluctuating eye pressure, exfoliation syndrome, and poor compliance being key risk factors for vision loss.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Public Health
Background:
- Glaucoma and ocular hypertension are leading causes of irreversible blindness worldwide.
- Effective management aims to prevent vision loss, but long-term outcomes require study.
Purpose of the Study:
- To determine the lifetime incidence of blindness in patients with treated glaucoma or ocular hypertension.
- To identify factors associated with the development of blindness in this cohort.
Main Methods:
- Retrospective analysis of 106 deceased patients (1991-2002) diagnosed with primary open-angle glaucoma, exfoliation glaucoma, or ocular hypertension.
- Evaluation of clinical records, causes of death, and visual status (acuity and visual fields) at the last visit.
Main Results:
- 14% of patients were bilaterally blind at their last visit; 16% were visually handicapped.
- Glaucoma caused blindness in one or both eyes in 15% of patients.
- Risk factors for blindness included advanced glaucoma at diagnosis, intraocular pressure fluctuations, exfoliation syndrome, and poor patient compliance.
Conclusions:
- Blindness in glaucoma patients is linked to disease severity at diagnosis and treatment adherence.
- Exfoliation syndrome and fluctuating intraocular pressure are significant contributors to vision loss.
- The cumulative incidence of bilateral blindness from glaucoma was 6%.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Photoreceptors and Visual Pathways
Diabetic Retinopathy
